Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A randomized and parallel controlled trial design of comparing the new treatment group of Roxadustat combined with Sacubitril Valsartan Sodium Tablets with the traditional treatment group of recombinant human erythropoietin (EPO) combined with ACEI or ARB in Chinese patients with cardiorenal anemia syndrome.
Epistemonikos ID: 233a0e4b6bdcf0333343df678f1b1d0ed11a7da4
First added on: May 09, 2024